INTECH Investment Management’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,371
Closed -$349K – 2133
2026
Q2
$349K Buy
8,371
+1,336
+19% +$49.1K ﹤0.01% 1504
2026
Q1
$220K Sell
7,035
-991
-12% -$27.9K ﹤0.01% 1709
2025
Q4
$244K Buy
+8,026
New +$222K ﹤0.01% 1871
2025
Q3
– Sell
-11,462
Closed -$130K – 2537
2025
Q2
$130K Buy
+11,462
New +$122K ﹤0.01% 2220

Other funds holding RAPP

INTECH Investment Management's RAPP Position: Q3 2026 in Review

INTECH Investment Management sold out of Rapport Therapeutics (RAPP) in Q3 2026, closing a stake of 8,371 shares — an estimated $349K sold.

INTECH Investment Management first reported a position in RAPP in Q2 2025 and held it in 4 quarters. The position peaked at $349K in Q2 2026. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • INTECH Investment Management reported no remaining Rapport Therapeutics position as of Q3 2026 after selling out during the quarter.
  • INTECH Investment Management sold 8,371 Rapport Therapeutics shares in Q3 2026, an estimated $349K.
  • INTECH Investment Management first reported a position in Rapport Therapeutics in Q2 2025 and held it in 4 quarters.
  • INTECH Investment Management's Rapport Therapeutics position peaked at $349K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.